Schroder Investment Management Group
PDLI

Schroder Investment Management Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Schroder Investment Management Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-303,534
Closed -$783K – 1423
2017
Q2 		$783K Sell
303,534
-107,762
-26% -$248K ﹤0.01% 1010
2017
Q1 		$888K Buy
411,296
+279,863
+213% +$619K ﹤0.01% 969
2016
Q4 		$279K Sell
131,433
-15,848
-11% -$44.2K ﹤0.01% 1012
2016
Q3 		$493K Sell
147,281
-67,598
-31% -$215K ﹤0.01% 974
2016
Q2 		$675K Sell
214,879
-52,056
-20% -$174K ﹤0.01% 947
2016
Q1 		$846K Buy
+266,935
New +$832K ﹤0.01% 933
2015
Q1 		– Sell
-8,684,695
Closed -$67M – 1416
2014
Q4 		$67M Sell
8,684,695
-37,500
-0.4% -$297K 0.13% 196
2014
Q3 		$65.2M Sell
8,722,195
-6,945
-0.1% -$64.5K 0.09% 215
2014
Q2 		$84.5M Sell
8,729,140
-67,900
-0.8% -$605K 0.11% 177
2014
Q1 		$73.1M Buy
8,797,040
+3,675,872
+72% +$31.5M 0.08% 199
2013
Q4 		$43.2M Buy
5,121,168
+852,600
+20% +$7.19M 0.05% 286
2013
Q3 		$34M Buy
4,268,568
+805,200
+23% +$6.47M 0.08% 297
2013
Q2 		$26.7M Buy
+3,463,368
New +$27M 0.07% 330

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Schroder Investment Management Group's PDLI Position: Q3 2017 in Review

Schroder Investment Management Group sold out of PDL BioPharma, Inc. (PDLI) in Q3 2017, closing a stake of 303,534 shares — an estimated $783K sold.

Schroder Investment Management Group first reported a position in PDLI in Q2 2013 and held it in 13 quarters. The position peaked at $84.5M in Q2 2014. 186 funds tracked by Wall St. Rank hold PDLI as of Q3 2017.

  • Schroder Investment Management Group reported no remaining PDL BioPharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Schroder Investment Management Group sold 303,534 PDL BioPharma, Inc. shares in Q3 2017, an estimated $783K.
  • Schroder Investment Management Group first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 13 quarters.
  • Schroder Investment Management Group's PDL BioPharma, Inc. position peaked at $84.5M in Q2 2014.
  • 186 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2017.

Based on Schroder Investment Management Group's 13F filing for Q3 2017, filed 9 Nov 2017.